Evidence map›Paper›PMID 30150735›Full record

ReviewNature microbiology2019

Vector biology meets disease control: using basic research to fight vector-borne diseases.

W Robert Shaw, Flaminia Catteruccia

Abstract readReview
In one paragraph

Review in Nature microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Fungal microbiota diversity inWellcome open research · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Detection of novelFrontiers in microbiology · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

W Robert ShawHarvard T. H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, MA, USA. wrshaw@hsph.harvard.edu.ORCID http://orcid.org/0000-0002-2806-9718
Flaminia CatterucciaHarvard T. H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, MA, USA. fcatter@hsph.harvard.edu.ORCID http://orcid.org/0000-0003-3295-6683

Funding

Targeting steroid hormone signaling in Anopheles mosquitoes for malaria controlR01AI124165 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI CATTERUCCIA, FLAMINIA · 2016 to 2020
$3.4M
NIAID NIH HHS R01 AI124165
6 · The paper itself

Abstract

Human pathogens that are transmitted by insects are a global problem, particularly those vectored by mosquitoes; for example, malaria parasites transmitted by Anopheles species, and viruses such as dengue, Zika and chikungunya that are carried by Aedes mosquitoes. Over the past 15 years, the prevalence of malaria has been substantially reduced and virus outbreaks have been contained by controlling mosquito vectors using insecticide-based approaches. However, disease control is now threatened by alarming rates of insecticide resistance in insect populations, prompting the need to develop a new generation of specific strategies that can reduce vector-mediated transmission. Here, we review how increased knowledge in insect biology and insect-pathogen interactions is stimulating new concepts and tools for vector control. We focus on strategies that either interfere with the development of pathogens within their vectors or directly impact insect survival, including enhancement of vector-mediated immune control, manipulation of the insect microbiome, or use of powerful new genetic tools such as CRISPR-Cas systems to edit vector genomes. Finally, we offer a perspective on the implementation hurdles as well as the knowledge gaps that must be filled in the coming years to safely realize the potential of these novel strategies to eliminate the scourge of vector-borne disease.

Indexed as

AedesAnimalsAnophelesBiological Control AgentsCommunicable Disease ControlCommunicable DiseasesCulexDisease OutbreaksHumansInsect ControlInsecticide ResistanceInsecticidesMosquito VectorsWolbachiaBiological Control AgentsInsecticides

Identifiers

PMID30150735
PMCPMC6437764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.